Sirio Pharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Cash & Equivalents	541.55	636.03	534.49	1,502	715.54	216.7	Upgrade
Short-Term Investments	-	25.17	20	109.26	-	-	Upgrade
Trading Asset Securities	10.41	115.2	200.66	79.13	530.77	473.49	Upgrade
Cash & Short-Term Investments	551.95	776.4	755.14	1,690	1,246	690.2	Upgrade
Cash Growth	-13.41%	2.81%	-55.32%	35.60%	80.57%	74.56%	Upgrade
Accounts Receivable	848.98	702.53	652.86	476.96	372.33	307.1	Upgrade
Other Receivables	12.6	20.81	4.99	4.45	4.27	3.13	Upgrade
Receivables	861.58	723.34	657.85	481.41	376.6	310.22	Upgrade
Inventory	548.57	481.66	481.06	232.58	239.61	266.77	Upgrade
Other Current Assets	99.24	41.54	38.87	28.58	51.99	56.64	Upgrade
Total Current Assets	2,061	2,023	1,933	2,433	1,915	1,324	Upgrade
Property, Plant & Equipment	2,264	2,093	1,913	1,332	1,173	768.05	Upgrade
Long-Term Investments	159.4	52.44	94.11	-	337.79	152.22	Upgrade
Goodwill	431.98	417.1	420.73	163.05	158.59	176.28	Upgrade
Other Intangible Assets	523.15	525.92	544.84	178.33	160.75	128.97	Upgrade
Long-Term Deferred Tax Assets	115.71	81.36	32.48	13.75	16.31	33.75	Upgrade
Long-Term Deferred Charges	259.36	258.14	201.92	59.45	53	48.55	Upgrade
Other Long-Term Assets	62.57	34.66	55.99	7.14	6.57	17.98	Upgrade
Total Assets	5,878	5,486	5,196	4,186	3,820	2,650	Upgrade
Accounts Payable	458.75	393.43	398.13	259.25	195.71	199.52	Upgrade
Accrued Expenses	99.51	92.51	104.39	152.33	79.6	71.21	Upgrade
Short-Term Debt	129.26	54.82	-	0.16	0.12	1.61	Upgrade
Current Portion of Long-Term Debt	80.78	40.59	21.25	-	-	33.1	Upgrade
Current Portion of Leases	-	27.09	42.8	7.26	5.19	-	Upgrade
Current Income Taxes Payable	64.17	48.07	11.39	11.03	10.18	21.58	Upgrade
Current Unearned Revenue	39.73	36.92	53.13	25.83	28.22	43.11	Upgrade
Other Current Liabilities	216.71	131.1	120.04	13.84	13.43	16.93	Upgrade
Total Current Liabilities	1,089	824.54	751.13	469.69	332.44	387.06	Upgrade
Long-Term Debt	1,172	1,156	1,049	908.36	852.28	-	Upgrade
Long-Term Leases	324.29	328.39	256.16	21.14	16.68	-	Upgrade
Long-Term Unearned Revenue	72.19	59.7	65.68	62.4	61.48	65.25	Upgrade
Long-Term Deferred Tax Liabilities	14.78	15.15	28.08	22.69	12.44	14.64	Upgrade
Other Long-Term Liabilities	456.12	461.44	479.47	0.01	-	-	Upgrade
Total Liabilities	3,128	2,845	2,630	1,484	1,275	466.94	Upgrade
Common Stock	307.32	235.87	181.56	180.5	180.17	120	Upgrade
Additional Paid-In Capital	451.99	500.7	547.5	1,048	1,045	1,081	Upgrade
Retained Earnings	1,730	1,623	1,496	1,278	1,138	978.14	Upgrade
Treasury Stock	-66.16	-54.31	-44.53	-	-	-	Upgrade
Comprehensive Income & Other	230.47	200.88	209.37	195.13	181.35	3.75	Upgrade
Total Common Equity	2,654	2,506	2,390	2,702	2,545	2,183	Upgrade
Minority Interest	95.62	135.36	176.14	-	0.01	0.01	Upgrade
Shareholders' Equity	2,750	2,641	2,566	2,702	2,545	2,183	Upgrade
Total Liabilities & Equity	5,878	5,486	5,196	4,186	3,820	2,650	Upgrade
Total Debt	1,706	1,607	1,369	936.9	874.26	34.71	Upgrade
Net Cash (Debt)	-1,154	-830.1	-614.1	753.08	372.05	655.49	Upgrade
Net Cash Growth	-	-	-	102.42%	-43.24%	121.73%	Upgrade
Net Cash Per Share	-3.78	-2.73	-2.02	2.45	1.16	2.14	Upgrade
Filing Date Shares Outstanding	305.36	306.79	304.67	305.04	304.49	304.2	Upgrade
Total Common Shares Outstanding	305.36	304.96	304.67	305.04	304.49	304.2	Upgrade
Working Capital	972.44	1,198	1,182	1,963	1,582	936.77	Upgrade
Book Value Per Share	8.69	8.22	7.84	8.86	8.36	7.18	Upgrade
Tangible Book Value	1,699	1,563	1,424	2,360	2,225	1,877	Upgrade
Tangible Book Value Per Share	5.56	5.12	4.68	7.74	7.31	6.17	Upgrade
Buildings	-	1,067	1,000	890.28	528.67	478.54	Upgrade
Machinery	-	1,390	1,242	974.19	773.89	645.85	Upgrade
Construction In Progress	-	238.4	186.94	69.28	365.12	117.96	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.